182 related articles for article (PubMed ID: 37441534)
1. Targeted delivery of silibinin via magnetic niosomal nanoparticles: potential application in treatment of colon cancer cells.
Shafiei G; Jafari-Gharabaghlou D; Farhoudi-Sefidan-Jadid M; Alizadeh E; Fathi M; Zarghami N
Front Pharmacol; 2023; 14():1174120. PubMed ID: 37441534
[No Abstract] [Full Text] [Related]
2. Fabrication of magnetic niosomal platform for delivery of resveratrol: potential anticancer activity against human pancreatic cancer Capan-1 cell.
Firouzi Amandi A; Bahmanyar Z; Dadashpour M; Lak M; Natami M; Döğüş Y; Alem M; Adeli OA
Cancer Cell Int; 2024 Jan; 24(1):46. PubMed ID: 38287318
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of oxaliplatin via folate-decorated niosomal nanoparticles potentiates resistance reversion of colon cancer cells.
Abdulzehra S; Jafari-Gharabaghlou D; Zarghami N
Heliyon; 2023 Nov; 9(11):e21400. PubMed ID: 37954331
[TBL] [Abstract][Full Text] [Related]
4. Advanced nano-therapeutic delivery of metformin: potential anti-cancer effect against human colon cancer cells through inhibition of GPR75 expression.
Ghorbanzadeh F; Jafari-Gharabaghlou D; Dashti MR; Hashemi M; Zarghami N
Med Oncol; 2023 Jul; 40(9):255. PubMed ID: 37515667
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of curcumin-Cu and curcumin-Ag nanoparticle loaded niosome: Enhanced antibacterial and anti-biofilm activities.
Targhi AA; Moammeri A; Jamshidifar E; Abbaspour K; Sadeghi S; Lamakani L; Akbarzadeh I
Bioorg Chem; 2021 Oct; 115():105116. PubMed ID: 34333420
[TBL] [Abstract][Full Text] [Related]
6. Efficient targeting of HIF-1α mediated by YC-1 and PX-12 encapsulated niosomes: potential application in colon cancer therapy.
Bakand A; Moghaddam SV; Naseroleslami M; André H; Mousavi-Niri N; Alizadeh E
J Biol Eng; 2023 Sep; 17(1):58. PubMed ID: 37749603
[TBL] [Abstract][Full Text] [Related]
7. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study.
Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M
Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236
[TBL] [Abstract][Full Text] [Related]
8. The silibinin-loaded Zein-β cyclodextrin nano-carriers (SZBC-NCs) as a novel selective cancer cell drug delivery system in HT-29 cell line.
Al Alabdullah MAA; Goodarzi MT; Homayouni Tabrizi M
Sci Rep; 2024 Jun; 14(1):14769. PubMed ID: 38926533
[TBL] [Abstract][Full Text] [Related]
9. Preparation, Characterization and Cytotoxicity of Silibinin- Containing Nanoniosomes in T47D Human Breast Carcinoma Cells.
Amiri B; Ebrahimi-Far M; Saffari Z; Akbarzadeh A; Soleimani E; Chiani M
Asian Pac J Cancer Prev; 2016; 17(8):3835-8. PubMed ID: 27644625
[TBL] [Abstract][Full Text] [Related]
10. Niosomes-loaded selenium nanoparticles as a new approach for enhanced antibacterial, anti-biofilm, and anticancer activities.
Haddadian A; Robattorki FF; Dibah H; Soheili A; Ghanbarzadeh E; Sartipnia N; Hajrasouliha S; Pasban K; Andalibi R; Ch MH; Azari A; Chitgarzadeh A; Kashtali AB; Mastali F; Noorbazargan H; Mirzaie A
Sci Rep; 2022 Dec; 12(1):21938. PubMed ID: 36536030
[TBL] [Abstract][Full Text] [Related]
11. Effect of silibinin-loaded nano-niosomal coated with trimethyl chitosan on miRNAs expression in 2D and 3D models of T47D breast cancer cell line.
Yazdi Rouholamini SE; Moghassemi S; Maharat Z; Hakamivala A; Kashanian S; Omidfar K
Artif Cells Nanomed Biotechnol; 2018 May; 46(3):524-535. PubMed ID: 28509572
[TBL] [Abstract][Full Text] [Related]
12. Fabricating niosomal-PEG nanoparticles co-loaded with metformin and silibinin for effective treatment of human lung cancer cells.
Salmani-Javan E; Jafari-Gharabaghlou D; Bonabi E; Zarghami N
Front Oncol; 2023; 13():1193708. PubMed ID: 37664043
[TBL] [Abstract][Full Text] [Related]
13. Magnetic-core-based silibinin nanopolymeric carriers for the treatment of renal cell cancer.
Takke A; Shende P
Life Sci; 2021 Jun; 275():119377. PubMed ID: 33757771
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic potentials of silibinin assisted silver nanoparticles on human colorectal HT-29 cancer cells.
Jackson K; Devaraj E; Lakshmi T; Rajeshkumar S; Dua K; Chellappan DK; Raghunandhakumar S
Bioinformation; 2020; 16(11):817-827. PubMed ID: 34803254
[TBL] [Abstract][Full Text] [Related]
15. Targeting Colorectal Cancer Cells with Niosomes Systems Loaded with Two Anticancer Drugs Models; Comparative In Vitro and Anticancer Studies.
El-Far SW; Abo El-Enin HA; Abdou EM; Nafea OE; Abdelmonem R
Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890115
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cytotoxicity and apoptosis-induced anticancer effect of silibinin-loaded nanoparticles in oral carcinoma (KB) cells.
Gohulkumar M; Gurushankar K; Rajendra Prasad N; Krishnakumar N
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():274-82. PubMed ID: 24907761
[TBL] [Abstract][Full Text] [Related]
17. The anticancer impact of folate-linked ZnO-decorated bovine serum albumin/silibinin nanoparticles on human pancreatic, breast, lung, and colon cancers.
Sadeghzadeh F; Golestani P; Beyramabdi P; Pouresmaeil V; Hosseini H; Homayouni Tabrizi M
J Biomater Sci Polym Ed; 2024 May; ():1-18. PubMed ID: 38809850
[TBL] [Abstract][Full Text] [Related]
18. In vitro Development of Controlled-Release Nanoniosomes for Improved Delivery and Anticancer Activity of Letrozole for Breast Cancer Treatment.
Ahmadi S; Seraj M; Chiani M; Hosseini S; Bazzazan S; Akbarzadeh I; Saffar S; Mostafavi E
Int J Nanomedicine; 2022; 17():6233-6255. PubMed ID: 36531115
[TBL] [Abstract][Full Text] [Related]
19. hTERT-molecular targeted therapy of ovarian cancer cells via folate-functionalized PLGA nanoparticles co-loaded with MNPs/siRNA/wortmannin.
Ghareghomi S; Ahmadian S; Zarghami N; Hemmati S
Life Sci; 2021 Jul; 277():119621. PubMed ID: 34004255
[TBL] [Abstract][Full Text] [Related]
20. Design and optimization various formulations of PEGylated niosomal nanoparticles loaded with phytochemical agents: potential anti-cancer effects against human lung cancer cells.
Shahbazi R; Jafari-Gharabaghlou D; Mirjafary Z; Saeidian H; Zarghami N
Pharmacol Rep; 2023 Apr; 75(2):442-455. PubMed ID: 36859742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
